Risk factors for primary site necrosis after definitive concurrent chemoradiotherapy in head and neck cancer.
Dong Hyeon KimYong Gan KiWontaek KimDahl ParkJihyeon JooHosang JeonKyeonghyo LeeJiho NamPublished in: Tumori (2021)
V70 ⩾79.8 mL is significantly related to the risk of developing PSN. These findings offer valuable clues for clinicians to minimize PSN incidence in HNC treated with curative CCRT.